Clinical studies recruiting near Tacoma

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Washington Gastroenterology - Tacoma- Site Number : 8400009 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Northwest Medical Specialties, PLLC · Pfizer · NCT07028853 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Northwest Medical Specialties, PLLC ( Site 0093) · Merck Sharp & Dohme LLC · NCT06393374 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Mary Bridge Children's Hospital and Health Center · National Cancer Institute (NCI) · NCT05099003 A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Phase 2 · Digestive Health Specialists · Boehringer Ingelheim · NCT06636656 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Mary Bridge Children's Hospital and Health Center · National Cancer Institute (NCI) · NCT06172296 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Northwest Medical Specialties PPLC (P1 Trials - Exigent Netw · Shanghai Henlius Biotech · NCT07160335 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Mary Bridge Children's Hospital and Health Center · National Cancer Institute (NCI) · NCT05691478 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Washington Gastroenterology - Tacoma · Eli Lilly and Company · NCT07415044 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 2141 · Turning Point Therapeutics, Inc. · NCT03093116 Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Phase 2 · Madigan Army Medical Center · Henry M. Jackson Foundation for the Advancement of Military · NCT05049057 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Mary Bridge Children's Hospital and Health Center · Children's Oncology Group · NCT04322318 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Multicare Health System - Mary Bridge Pediatrics · Longboard Pharmaceuticals · NCT06660394 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Washington Gastroenterology - Tacoma · Eli Lilly and Company · NCT06937086 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Northwest Medical Specialties, PLLC · Amgen · NCT07005128 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Franciscan Research Center-Northwest Medical Plaza · NRG Oncology · NCT05174169 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Mary Bridge Children's Outpatient Center - Tacoma · SAb Biotherapeutics, Inc. · NCT07187531 A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic
Phase 3 · Study Site 103 · Grifols Biologicals, LLC · NCT07582432 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · MultiCare Health System - Mary Bridge Children's Health Cent · Eli Lilly and Company · NCT06672549 SLV-154 Treatment of Advanced Cancers
Phase 1 · Northwest Medical Specialties, PLLC · Solve Therapeutics · NCT06771219 A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Out
Phase N/A · MultiCare Health System Institute · Novartis Pharmaceuticals · NCT07091019 A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · Washington Gastroenterology- GIA · Takeda · NCT06095128 Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Phase N/A · MultiCare Health System · Novartis Pharmaceuticals · NCT04174157 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Northwest Medical Specialties, PLLC · Pfizer · NCT06629779 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Franciscan Research Center-Northwest Medical Plaza · National Cancer Institute (NCI) · NCT04269902 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Multicare Cancer Institute Tacoma General Hospital · BeOne Medicines · NCT07492641 Volrustomig Priming Regimens Exploratory Phase II Platform Study
Phase 2 · Research Site · AstraZeneca · NCT06448754

Look up another city

Look up another condition